ELCIX
Price
$50.46
Change
-$1.03 (-2.00%)
Updated
Nov 13 closing price
Net Assets
472.22M
RGACX
Price
$84.05
Change
-$1.88 (-2.19%)
Updated
Nov 13 closing price
Net Assets
340.4B
Interact to see
Advertisement

ELCIX vs RGACX

Header iconELCIX vs RGACX Comparison
Open Charts ELCIX vs RGACXBanner chart's image
Eaton Vance Growth I
Price$50.46
Change-$1.03 (-2.00%)
VolumeN/A
Net Assets472.22M
American Funds Growth Fund of Amer R3
Price$84.05
Change-$1.88 (-2.19%)
VolumeN/A
Net Assets340.4B
ELCIX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
ELCIX vs. RGACX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELCIX is a Buy and RGACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 340B vs. ELCIX (472M). RGACX pays higher dividends than ELCIX: RGACX (0.07) vs ELCIX (0.00). ELCIX was incepted earlier than RGACX: ELCIX (19 years) vs RGACX (24 years). RGACX (0.94) is less costly to investors than ELCIX (0.79). RGACX is a more actively managed with annual turnover of: 25.00 vs. ELCIX (18.00). RGACX has a lower initial minimum investment than ELCIX: RGACX (250) vs ELCIX (1000000). RGACX annual gain was more profitable for investors over the last year : 8.31 vs. ELCIX (6.59). RGACX (37.90) and ELCIX (36.34) have equivalent 5 years return.
ELCIXRGACXELCIX / RGACX
Total Expense Ratio0.790.9484%
Annual Report Gross Expense Ratio0.790.9484%
Fund Existence19 years24 years-
Gain YTD13.98219.36472%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets472M340B0%
Annual Yield % from dividends0.000.07-
Returns for 1 year6.598.3179%
Returns for 3 years64.6363.31102%
Returns for 5 years36.3437.9096%
Returns for 10 years120.6498.36123%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CZAR32.25N/A
N/A
Themes Natural Monopoly ETF
GEND11.30-0.01
-0.08%
Genter Capital Dividend Income ETF
IBDX25.48-0.09
-0.35%
iShares iBonds Dec 2032 Term Corp ETF
EWN58.61-0.42
-0.71%
iShares MSCI Netherlands ETF
GSJY46.68-0.63
-1.34%
Goldman Sachs ActiveBeta® Japan Eq ETF